VTC Hosts LTBI R01 Meeting
The Vanderbilt Tuberculosis Center recently hosted a meeting of researchers involved in our LTBI R01 project “Immunogenetic predictors of active and incipient TB in HIV-negative and -positive close TB contacts” (NIH R01AI147765). The event, which took place between March 21st and 22nd, and included presentations about ongoing research and data findings, working group sessions, and breakout meetings.
RePORT-Brazil Investigators at CROI 2024
The 2024 Conference on Retroviruses and Opportunistic Infections (CROI) in Denver was attended by investigators from RePORT-Brazil, including presentations on recent findings and articles.
Poster Presentations:
Dr. Gustavo Amorim, PhD - "Estimating Optimal Anti-TB Drug Concentrations in a Prospective, Observational Cohort in Brazil"
Dr. Felipe Ridolfi, PhD, MD - “Pharmacogenetic Associations With HIV-1 Virologic Suppression Among Patients with TB/HIV in Brazil”
RePORT-Brazil in the Spotlight - CID Article
A recently publication in the journal Clinical Infectious Diseases is catching attention. The Xpert® MTB/RIF cycle threshold value predicts M. tuberculosis transmission to close contacts in a Brazilian prospective multicenter cohort was published by the RePORT-Brazil consortium, with authorship being led by the team at the Fundação de Medicina Tropical in Manaus, Amazonas, Brazil.
TBTC Launches CRUSH-TB trial
CDC’s Tuberculosis Trials Consortium (TBTC) has recently launched the CRUSH-TB trial, which aims to identify new combinations of drugs to shorten treatment of active TB disease. Kelly Dooley, MD, PhD, MPH, Director, Division of Infectious Diseases, is a Protocol Chair for this new study.
Read more from CDC’s TB Notes newsletter:
Felipe Ridolfi, MD, PhD, completes year at VUMC
Felipe Ridolfi, MD, MSc, recently completed his Ph.D. sandwich program at VUMC, where he was hosted by the TB Center. Here a few highlights of his time with us.
VUMC investigators attend RePORT-International Annual Meeting in Goa, India
VUMC investigators and staff, Timothy Sterling, Yuri van der Heijden, Stephany Duda, Marina Figueiredo, Fernanda Mauri, Megan Turner, Maria Arriaga, and Austin Katona; attended the annual RePORT International meeting that was held in Goa, India September 6, 7 and 8, 2023.
Aurum Leadership Visit VUMC
Prof. Gavin Churchyard, CEO; Mr. Arshad Hassim, CFO; and Dr. Violet Chihota, Chief Specialist Scientist of the Aurum Institute, visited VUMC from August 21st to August 25th. Their visit strengthens the ongoing collaborative partnership between the two institutions, which is focused on research and global health. Included in the visit were a variety of strategic planning meetings, programmatic evaluations, and a presentation at ID Grand Rounds by Dr. Violet Chihota.
Dr. María Belen Arriaga Gutiérrez receives 2023 CAPES Thesis Award
Dr. María Belen Arriaga Gutiérrez, post-doctoral scholar at the Vanderbilt Tuberculosis Center, recently received commendations for her doctoral thesis "Clinical and Epidemiologic Determinants of Susceptibility to Infection by Mycobacterium tuberculosis and the Therapeutic Responses in Patients with Tuberculosis” from the Brazilian Department of Education and CAPES, Coordination for the Improvement of Higher Education.
RePORT-Brazil in the Spotlight - Discoveries in Medicine
Published on July 12, 2023 in Discoveries in Medicine, Research into TB Expands Internationally, is based off of an interview with Timothy R.
TB Center joins 3rd Iteration of RePORT-International Coordinating Center
The Vanderbilt TB Center is returning to the leadership team of the RePORT International Coordinating Center, for its 3rd iteration.
VTC Hosts TB/HIV R01 Meeting
Vanderbilt Tuberculosis Center recently hosted a meeting of researchers involved in our TB/HIV grant "Predictors of treatment toxicity, failure, and relapse in HIV-related tuberculosis" (NIH R01AI120790-04). The event, which took place on April 26th and 27th, included presentations on the results and findings of each working group, breakout sessions, and discussions on future steps to be taken and larger goals of the research.